BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 10, 2009
View Archived Issues
Cardiome Gets Much-Needed Deal in $800M Merck Alliance
Shares of Cardiome Pharma Corp. shot up 25 percent after it scored a crucial partnership for its late-stage atrial fibrillation drug, vernakalant. (BioWorld Today)
Read More
After PML Cases, Genentech Takes Raptiva off the Market
Read More
Mechanistics Guide Drug for Advanced Prostate Cancer
Read More
Celldex Dusting Off Program Idled Years Ago by Amgen
Read More
Clinic Roundup
Read More
Other News To Note
Read More
Financings Roundup
Read More